KRT8 anticorps
Aperçu rapide pour KRT8 anticorps (ABIN7249764)
Antigène
Voir toutes KRT8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogène
- KLH conjugated Synthetic peptide corresponding to Mouse Cytokeratin 8
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, IHC 1:200-1:800
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 430 μg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 1 % BSA and 50 % glycerol, pH 7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- KRT8 (Keratin 8 (KRT8))
-
Autre désignation
- CK-8
-
Sujet
- Cytokeratin 8 (CK8) has a molecular weight of 52.5 KDa, which belongs to the HMW (high molecular weight) B-type Cytokeratin. CK8 is mainly marked on non-squamous epithelium, thus can be used for the diagnosis of adenocarcinoma and ductal carcinoma. Generally, CK8 is not expressed in squamous cell carcinoma. It is reported that hepatocellular carcinoma mainly express CK8 and CK18.
-
Poids moléculaire
-
Observed_MW: 54 kDa
Calculated_MW: 54 kDa
-
UniProt
- P05787, P11679, Q10758
Antigène
-